Randomized controlled trial comparing highly purified (HP-hCG) and recombinant hCG (r-hCG) for triggering ovulation in ART

• Published in: Gynecological endocrinology Vol. 29; no. 2; pp. 93 - 97
• Main Authors: Bellavia, Marina, de Geyter, Christian, Streuli, Isabelle, Ibecheole, Victoria, Birkhäuser, Martin H., Cometti, Barbara P. S., de Ziegler, Dominique
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare 01.02.2013; Taylor & Francis
• Subjects: Adult; Birth Rate; Chorionic Gonadotropin - adverse effects; Chorionic Gonadotropin - chemistry; Chorionic Gonadotropin - genetics; Chorionic Gonadotropin - pharmacology; COH; Embryo Implantation; Family Characteristics; Female; Fertility Agents, Female - administration & dosage; Fertility Agents, Female - adverse effects; Fertility Agents, Female - chemistry; Fertility Agents, Female - pharmacology; Fertilization in Vitro; hCG; highly purified; Humans; Infertility, Female - etiology; Infertility, Female - therapy; Infertility, Male - physiopathology; Injections, Subcutaneous; Male; Oocyte Retrieval; Ovary - drug effects; Ovulation Induction - methods; Pregnancy; Pregnancy Rate; Recombinant Proteins - administration & dosage; Recombinant Proteins - adverse effects; Recombinant Proteins - pharmacology; Single-Blind Method; Sperm Injections, Intracytoplasmic; Switzerland - epidemiology; triggering ovulation; Switzerland

Background: A randomized controlled trial (RCT) comparing highly purified human Choriogonadotrophin (HP-hCG) and recombinant hCG (r-hCG) both administered subcutaneously for triggering ovulation in controlled ovarian stimulation (COS) for Assisted Reproductive Technology (ART). Methods: Multi-centre...